4-(2-fluoroethoxy)aniline | 1547-12-2

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: 4-(2-fluoroethoxy)aniline
• 英文别名: p-fluoroethoxyaniline
• CAS: 1547-12-2
• 化学式: C₈H₁₀FNO
• 分子量: 155.172
• InChiKey: MLFLCOQJVCANJG-UHFFFAOYSA-N

物化性质

• 沸点：
  268.4±20.0 °C(Predicted)
• 密度：
  1.127±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.2
• 重原子数：
  11
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  35.2
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  4-(2-fluoroethoxy)aniline 在 盐酸 、 bathophenanthrolinedispufonic acid disodium salt 、 copper(II) sulfate 、 sodium ascorbate 、 sodium nitrite 作用下， 以 水 、 N,N-二甲基甲酰胺 为溶剂， 生成 ethyl 1-(4-(2-fluoroethoxy)phenyl)-1H-1,2,3-triazole-4-carboxylate
  参考文献：
  名称：

  Synthesis and Structure–Activity Relationship Studies of Conformationally Flexible Tetrahydroisoquinolinyl Triazole Carboxamide and Triazole Substituted Benzamide Analogues as σ₂ Receptor Ligands

  摘要：

  Two novel classes of compounds targeting the sigma-2 (sigma(2)) receptor were synthesized, and their bioactivities to binding sigma(1) and sigma(2) receptors were measured. Four novel triazole carboxamide analogues, 24d, 24e, 24f, and 39c, demonstrated high affinity and selectivity for the sigma(2) receptor. These data suggest C-11-labeled versions of these compounds may be potential sigma(2)-selective radiotracers for imaging the proliferative status of solid tumors.

  DOI：

  10.1021/jm5001453
• 作为产物：
  描述：

  tert-butyl (4-(2-fluoroethoxy)phenyl)carbamate 在 盐酸 作用下， 以 水 、 乙酸乙酯 为溶剂， 以98.6%的产率得到4-(2-fluoroethoxy)aniline
  参考文献：
  名称：

  Synthesis and Structure–Activity Relationship Studies of Conformationally Flexible Tetrahydroisoquinolinyl Triazole Carboxamide and Triazole Substituted Benzamide Analogues as σ₂ Receptor Ligands

  摘要：

  Two novel classes of compounds targeting the sigma-2 (sigma(2)) receptor were synthesized, and their bioactivities to binding sigma(1) and sigma(2) receptors were measured. Four novel triazole carboxamide analogues, 24d, 24e, 24f, and 39c, demonstrated high affinity and selectivity for the sigma(2) receptor. These data suggest C-11-labeled versions of these compounds may be potential sigma(2)-selective radiotracers for imaging the proliferative status of solid tumors.

  DOI：

  10.1021/jm5001453

文献信息

• Synthesis, labelling and evaluation of hydantoin-substituted indole carboxylic acids as potential ligands for positron emission tomography imaging of the glycine binding site of the N-methyl-d-aspartate receptor
  作者：A. Bauman、M. Piel、S. Höhnemann、A. Krauss、M. Jansen、C. Solbach、G. Dannhardt、F. Rösch

  DOI：10.1002/jlcr.1901

  日期：2011.8

  hydroxy moiety to obtain the radiolabelled ligands through an alkylation reaction. Radiosynthesis was achieved by labelling the precursor ethyl 4,6-dichloro-3-((3-(4-hydroxyphenyl)-2,4-dioxoimidazolidin-1-yl)methyl)-indole-2-carboxylate with 2-[18F]fluoroethyl tosylate or [11C]methyl iodide and subsequent cleavage of the ethyl ester moiety. This gave the final products in overall decay-corrected radiochemical

  N-甲基-d-天冬氨酸（NMDA）受体作为一种离子型谷氨酸能受体对于生理过程如学习、记忆和突触可塑性是必不可少的。谷氨酸诱导的这些受体过度激活，伴随着细胞内钙浓度的增加，会导致细胞损伤并导致大量急性或慢性神经系统疾病，如中风、外伤、帕金森病和阿尔茨海默病。为了用正电子发射断层扫描可视化体内谷氨酸能神经传递，合成了基于乙内酰脲取代的吲哚-2-羧酸的先导结构的新型氟乙氧基和甲氧基取代的参考化合物。NMDA 受体对甘氨酸结合位点的亲和力显示 Ki 值介于 322 和 11 nM 之间，亲脂性的 logD 值介于 1.51 到 2.53 之间。在这些结果的基础上，合成了含有酚羟基部分的前体化合物，以通过烷基化反应获得放射性标记的配体。通过用 2-[18F] 标记前体 4,6-二氯-3-((3-(4-羟基苯基)-2,4-dioxoimidazolidin-1-yl)methyl)-indole-2-carboxylate
• 一种含氟苯并咪唑类化合物及其制备方法和应用
  申请人：上海泰坦科技股份有限公司

  公开号：CN108640878A

  公开（公告）日：2018-10-12

  本发明提供一种含氟苯并咪唑类化合物及其制备方法和应用，所述含氟苯并咪唑类化合物具有式I所示结构，其结构简单，具有良好的抗凝血活性，可以延长凝血时间，所述化合物的制备方法简单高效，易于实现工业化生产。
• [EN] CARBAZOLE AND CARBOLINE COMPOUNDS FOR USE IN THE DIAGNOSIS, TREATMENT, ALLEVIATION OR PREVENTION OF DISORDERS ASSOCIATED WITH AMYLOID OR AMYOLID-LIKE PROTEINS<br/>[FR] COMPOSÉS DE CARBAZOLE ET DE CARBOLINE DESTINÉS À ÊTRE UTILISÉS DANS LE DIAGNOSTIC, LE TRAITEMENT, L'ATTÉNUATION OU LA PRÉVENTION DE TROUBLES ASSOCIÉS AUX PROTÉINES AMYLOÏDES ET DE TYPE AMYLOÏDE
  申请人：AC IMMUNE SA

  公开号：WO2015110263A1

  公开（公告）日：2015-07-30

  The present invention relates to novel compounds that can be employed in the diagnosis, treatment, alleviation or prevention of a group of disorders and abnormalities associated with amyloid proteins and amyloid-like proteins, such as Alzheimer's disease. Precursors for the preparation of the compounds according to the present invention are also provided.

  本发明涉及一种新型化合物，可用于诊断、治疗、缓解或预防与淀粉样蛋白和类淀粉样蛋白相关的一组疾病和异常，如阿尔茨海默病。本发明还提供了制备这些化合物的前体。
• Carbazole and Carboline Compounds for Use in the Diagnosis, Treatment, Alleviation or Prevention of Disorders Associated with Amyloid or Amyloid-Like Proteins
  申请人：AC IMMUNE SA

  公开号：US20170002005A1

  公开（公告）日：2017-01-05

  The present invention relates to novel compounds that can be employed in the diagnosis, treatment, alleviation or prevention of a group of disorders and abnormalities associated with amyloid proteins and amyloid-like proteins, such as Alzheimer's disease. Precursors for the preparation of the compounds according to the present invention are also provided.

  本发明涉及可用于诊断、治疗、缓解或预防与淀粉样蛋白和类淀粉样蛋白相关的一组疾病和异常的新化合物，如阿尔茨海默病。本发明还提供了制备这些化合物的前体。
• 一种含氟苯酰胺类化合物及其制备方法和应用
  申请人：上海泰坦科技股份有限公司

  公开号：CN108329229A

  公开（公告）日：2018-07-27

  本发明提供一种含氟苯酰胺类化合物及其制备方法和应用，所述含氟苯酰胺类化合物具有式I所示结构，其结构简单，具有良好的抗凝血活性，可以延长凝血时间，所述化合物的制备方法简单高效，易于实现工业化生产。